Shattuck Labs CTO sells 2,032 shares under plan
Shattuck Labs Chief Technical Officer Abhinav A. Shukla reported an option exercise and related share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Shattuck Labs Chief Technical Officer Abhinav A. Shukla reported an option exercise and related share sale. He exercised stock options for 2,032 shares of common stock at an exercise price of $3.57 per share and sold 2,032 shares in an open-market transaction at a weighted average price of $7.01 per share.
The transactions were carried out under a Rule 10b5-1 trading plan adopted on February 2, 2026, designed to sell shares received from option exercises only as needed to fund exercise costs and estimated tax withholding. Following these transactions, he directly holds 81,258 shares of common stock and 50,168 stock options.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,032 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,032 | $3.57 | $7K |
| Sale | Common Stock | 2,032 | $7.01 | $14K |
Footnotes (3)
- F1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person.
- F2. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
exercise price financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What options did the Shattuck Labs (STTK) CTO exercise in this Form 4?
Was the Shattuck Labs (STTK) CTO sale part of a Rule 10b5-1 plan?
What is the structure of the CTO’s Shattuck Labs (STTK) stock option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.